Showing results (41-50 of 390) with videos related to
Sort By:
Pageof 39
Annals of Neurology|June 21, 2006
Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal studyRichard A Rudick, Jar-Chi Lee, Jack Simon, et al.Annals of Neurology|July 29, 2008
Gray matter atrophy in multiple sclerosis: a longitudinal studyElizabeth Fisher, Jar-Chi Lee, Kunio Nakamura, et al.Journal of Computer Assisted Tomography|July 19, 2013
National variation of technical factors in computed tomography of the headDavid Thickman, Guoqiao Wang, Jaleh White, et al.Journal of the Neurological Sciences|December 23, 2008
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSSRichard A Rudick, Jar-Chi Lee, Kunio Nakamura, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosisThomas F Scott, Carol J Schramke, Gary CutterTherapeutic Advances in Neurological Disorders|July 24, 2018
Clinical trials in multiple sclerosis: milestonesYinan Zhang, Amber Salter, Gary Cutter, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 15, 2017
Which symptoms contribute the most to patients' perception of health in multiple sclerosis?Rivka Green, Gary Cutter, Michael Friendly, et al.Neurology|December 17, 2013
Assessing treatment response to interferon-β: is there a role for MRI?Ruth Dobson, Richard A Rudick, Ben Turner, et al.Annals of Neurology|September 1, 2005
Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutationIlka Warshawsky, Richard A Rudick, Susan M Staugaitis, et al.Neuroepidemiology|June 17, 2010
Validation of a self-report comorbidity questionnaire for multiple sclerosisMyles Horton, Richard A Rudick, Claire Hara-Cleaver, et al.Pageof 39